Space-Proven. AI-Driven. Life-Sustaining.
RENAPEX GEN-2.1 is the world’s first AI-controlled, autonomous renal care platform designed from inception for human spaceflight. Built for NASA/ESA interoperability and dual-use applications on Earth, RENAPEX safeguards astronaut health during long-duration missions—where time, communication, and resources are limited.
Designed for Space. Built for Survival.
Designed for Space. Built for Survival.– 
Autonomous Renal & Hydration Control: Full AI regulation of filtration, hydration, and waste.
– 
Cybersecure Architecture: Built on SE-L4 Zero Trust OS with redundant failover systems.
– 
Modular Plug-and-Play Design: Compatible with ISS, Gateway, and future planetary habitats.
– 
Radiation Shielded & Power-Efficient: Optimized for microgravity + high-radiation zones.
– 
Sterilization + Emergency Waste Handling: Dual-valve UV-C system ensures safety.
Applications Across Space & Earth
Applications Across Space & Earth| Domain | Use Case |
 Spaceflight | Astronaut renal care on Gateway, ISS, Artemis, Mars |
 Hospitals | ICU-grade autonomous dialysis & hydration support |
 Disaster Zones | Off-grid trauma support in remote/conflict settings |
 Military | Forward-operating autonomous care units |
 Planetary Bases | Medical payloads for Moon/Mars crew safety |
RENAPEX vs. Other Platforms
RENAPEX vs. Other Platforms| Feature | RENAPEX GEN-2.1 | Other Space Biohealth Systems |
| TRL Status | TRL-7 | TRL-5–6 avg. |
| AI Autonomy |  Full AI Control | Partial or None |
| Cybersecurity | SE-L4, Zero Trust |  Not specified |
| Radiation Safety | Shielded + Antioxidants | None |
| Dual-Use | ICU, disaster, military | Research-only |
| ISS/Gateway Integration | UPA-ready, ESA Columbus | Partial or pending |